Warby Parker Inc. (WRBY) Financial Analysis & Valuation | Quarter Chart
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vi... more
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lens... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $2.76B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Neil Harris Blumenthal |
| IPO Date | 2021-09-29 | CAGR | 15.33% |
| Employees | 4,036 | Website | www.warbyparker.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 1.63% | Total Yield | 1.63% |
WRBY chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $3.22B | P/E | 70.31 | Forward P/E | 36.6 | PEG | — |
| P/S | 0.72 | P/B | 1.69 | P/CF | 6.96 | P/FCF | 30.21 |
| Sales | $911.61M | Sales 1Y | 10.99% | Sales 3Y | 43.94% | Sales 5Y | 87.01% |
| EPS | $0.32 | EPS 1Y | -186.57% | EPS 3Y | -110.66% | EPS 5Y | -101.53% |
| Sales QoQ | -2.86% | EPS QoQ | 33.33% | Sales QoQ Avg | 2.62% | EPS QoQ Avg | -189.73% |
| Gross Margin | 54.68% | Operating Margin | 0.17% | Profit Margin | 0.85% | ROCE | 0.25% |
| ROA | 1% | ROE | 2% | Altman Z Score | 4.75 | Piotroski Score | 6 |
| Current Ratio | 2.27 | Quick Ratio | 2.01 | Cash Ratio | 1.79 | Op. CF Ratio | 0.18 |
| Debt/Equity | 0.64 | Debt/Assets | 0.32 | Lt Debt/Equity | 0.55 | Lt Debt/Cap. | 0.35 |
| Intrst Cov. | — | Inventory Turnover | 9.81 | Asset Turnover | 1.18 | Receivables Turnover | 438.27 |
| Enterprise Value | $3.22B | P/E Ratio | 70.31 |
| Forward P/E | 36.6 | PEG Ratio | — |
| P/S Ratio | 0.72 | P/B Ratio | 1.69 |
| P/CF Ratio | 6.96 | P/FCF Ratio | 30.21 |
| EPS | $0.32 | EPS Growth 1Y | -186.57% |
| EPS Growth 3Y | -110.66% | EPS Growth 5Y | -101.53% |
| Revenue Growth 1Y | 10.99% | Gross Margin | 54.68% |
| Operating Margin | 0.17% | Profit Margin | 0.85% |
| ROE | 2% | ROA | 1% |
| ROCE | 0.25% | Current Ratio | 2.27 |
| Quick Ratio | 2.01 | Cash Ratio | 1.79 |
| Debt/Equity | 0.64 | Interest Coverage | — |
| Altman Z Score | 4.75 | Piotroski Score | 6 |
Warby Parker Inc. (WRBY) valuation & financials
Warby Parker Inc. (WRBY) has a market capitalization of $2.76B and trades at a price-to-earnings ratio of 70.3. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Warby Parker Inc.'s revenue grew +11.0% over the last year.
Warby Parker Inc.'s next earnings report is scheduled for November 5, 2026 before market open (provider scheduled date); analysts estimate EPS of $0.09. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)